Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 316

1.

Potential predictors of hospital length of stay and hospital charges among patients with all-terrain vehicle injuries in rural Northeast Texas.

Miller A, Gallegly JD, Orsak G, Huff SD, Peters JA, Murry J, Ndetan H, Singh KP.

J Inj Violence Res. 2019 Dec 10;12(1). doi: 10.5249/jivr.v12i1.1219. [Epub ahead of print]

2.

Tuberculosis in hospitalised patients with HIV: clinical characteristics, mortality, and implications from the STAMP trial.

Gupta-Wright A, Fielding K, Wilson D, van Oosterhout JJ, Grint D, Mwandumba HC, Alufandika-Moyo M, Peters JA, Chiume L, Lawn SD, Corbett EL.

Clin Infect Dis. 2019 Nov 29. pii: ciz1133. doi: 10.1093/cid/ciz1133. [Epub ahead of print]

PMID:
31781758
3.

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets.

Alexander SPH, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, Fabbro D, Spedding M, Striessnig J, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2019 Dec;176 Suppl 1:S1-S20. doi: 10.1111/bph.14747.

4.

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors.

Alexander SPH, Cidlowski JA, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2019 Dec;176 Suppl 1:S229-S246. doi: 10.1111/bph.14750.

5.

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors.

Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2019 Dec;176 Suppl 1:S21-S141. doi: 10.1111/bph.14748.

6.

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors.

Alexander SPH, Fabbro D, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2019 Dec;176 Suppl 1:S247-S296. doi: 10.1111/bph.14751.

7.

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels.

Alexander SPH, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2019 Dec;176 Suppl 1:S142-S228. doi: 10.1111/bph.14749.

8.

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes.

Alexander SPH, Fabbro D, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2019 Dec;176 Suppl 1:S297-S396. doi: 10.1111/bph.14752.

9.

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters.

Alexander SPH, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2019 Dec;176 Suppl 1:S397-S493. doi: 10.1111/bph.14753.

10.

Family Health Leaders: Lessons on Living with Li-Fraumeni Syndrome across Generations.

Pantaleao A, Young JL, Epstein NB, Carlson M, Bremer RC, Khincha PP, Peters JA, Greene MH, Roy K, Achatz MI, Savage SA, Werner-Lin A.

Fam Process. 2019 Oct 24. doi: 10.1111/famp.12497. [Epub ahead of print]

PMID:
31647118
11.

Habitat explains patterns of population decline for an invasive crayfish.

Larson ER, Kreps TA, Peters B, Peters JA, Lodge DM.

Ecology. 2019 May;100(5):e02659. doi: 10.1002/ecy.2659. Epub 2019 Mar 28.

PMID:
30919952
12.

A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2.

Best AF, Tucker MA, Frone MN, Greene MH, Peters JA, Katki HA.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):293-302. doi: 10.1158/1055-9965.EPI-18-0584. Epub 2019 Jan 28.

PMID:
30692095
13.

Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.

Reddy KP, Gupta-Wright A, Fielding KL, Costantini S, Zheng A, Corbett EL, Yu L, van Oosterhout JJ, Resch SC, Wilson DP, Horsburgh CR Jr, Wood R, Alufandika-Moyo M, Peters JA, Freedberg KA, Lawn SD, Walensky RP.

Lancet Glob Health. 2019 Feb;7(2):e200-e208. doi: 10.1016/S2214-109X(18)30436-4.

14.

Couples coping with screening burden and diagnostic uncertainty in Li-Fraumeni syndrome: Connection versus independence.

Young JL, Pantaleao A, Zaspel L, Bayer J, Peters JA, Khincha PP, Bremer RC, Loud JT, Greene MH, Achatz MI, Savage SA, Werner-Lin A.

J Psychosoc Oncol. 2019 Mar-Apr;37(2):178-193. doi: 10.1080/07347332.2018.1543376. Epub 2018 Dec 28.

15.

Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.

Gupta-Wright A, Corbett EL, van Oosterhout JJ, Wilson D, Grint D, Alufandika-Moyo M, Peters JA, Chiume L, Flach C, Lawn SD, Fielding K.

Lancet. 2018 Jul 28;392(10144):292-301. doi: 10.1016/S0140-6736(18)31267-4. Epub 2018 Jul 20.

16.

High spectral resolution of gamma-rays at room temperature by perovskite CsPbBr3 single crystals.

He Y, Matei L, Jung HJ, McCall KM, Chen M, Stoumpos CC, Liu Z, Peters JA, Chung DY, Wessels BW, Wasielewski MR, Dravid VP, Burger A, Kanatzidis MG.

Nat Commun. 2018 Apr 23;9(1):1609. doi: 10.1038/s41467-018-04073-3.

17.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors.

Alexander SP, Christopoulos A, Davenport AP, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2017 Dec;174 Suppl 1:S17-S129. doi: 10.1111/bph.13878.

18.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Other ion channels.

Alexander SP, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2017 Dec;174 Suppl 1:S195-S207. doi: 10.1111/bph.13881.

19.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels.

Alexander SP, Peters JA, Kelly E, Marrion NV, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2017 Dec;174 Suppl 1:S130-S159. doi: 10.1111/bph.13879.

20.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview.

Alexander SP, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, Fabbro D, Spedding M, Striessnig J, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2017 Dec;174 Suppl 1:S1-S16. doi: 10.1111/bph.13882.

21.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors.

Alexander SP, Fabbro D, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2017 Dec;174 Suppl 1:S225-S271. doi: 10.1111/bph.13876.

22.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters.

Alexander SP, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2017 Dec;174 Suppl 1:S360-S446. doi: 10.1111/bph.13883.

23.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.

Alexander SP, Fabbro D, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2017 Dec;174 Suppl 1:S272-S359. doi: 10.1111/bph.13877.

24.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Voltage-gated ion channels.

Alexander SP, Striessnig J, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2017 Dec;174 Suppl 1:S160-S194. doi: 10.1111/bph.13884.

25.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors.

Alexander SP, Cidlowski JA, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2017 Dec;174 Suppl 1:S208-S224. doi: 10.1111/bph.13880.

26.

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.

Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA, Achatz MI, Chojniak R, Balieiro da Costa A, Santiago KM, Garber J, O'Neill AF, Eeles RA, Evans DG, Bleiker E, Sonke GS, Ruijs M, Loo C, Schiffman J, Naumer A, Kohlmann W, Strong LC, Bojadzieva J, Malkin D, Rednam SP, Stoffel EM, Koeppe E, Weitzel JN, Slavin TP, Nehoray B, Robson M, Walsh M, Manelli L, Villani A, Thomas DM, Savage SA.

JAMA Oncol. 2017 Dec 1;3(12):1634-1639. doi: 10.1001/jamaoncol.2017.1968. Erratum in: JAMA Oncol. 2018 Apr 1;4(4):590.

27.

Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort.

Mai PL, Khincha PP, Loud JT, DeCastro RM, Bremer RC, Peters JA, Liu CY, Bluemke DA, Malayeri AA, Savage SA.

JAMA Oncol. 2017 Dec 1;3(12):1640-1645. doi: 10.1001/jamaoncol.2017.1350.

28.

Surface PEG Grafting Density Determines Magnetic Relaxation Properties of Gd-Loaded Porous Nanoparticles for MR Imaging Applications.

Zhang W, Martinelli J, Peters JA, van Hengst JMA, Bouwmeester H, Kramer E, Bonnet CS, Szeremeta F, Tóth É, Djanashvili K.

ACS Appl Mater Interfaces. 2017 Jul 19;9(28):23458-23465. doi: 10.1021/acsami.7b05912. Epub 2017 Jul 7.

29.

Charge Transport and Observation of Persistent Photoconductivity in Tl6SeI4 Single Crystals.

Das S, Peters JA, Lin W, Kostina SS, Chen P, Kim JI, Kanatzidis MG, Wessels BW.

J Phys Chem Lett. 2017 Apr 6;8(7):1538-1544. doi: 10.1021/acs.jpclett.7b00336. Epub 2017 Mar 22.

PMID:
28300409
30.

Special Issue Introduction: Dealing with Psychological and Social Complexity in Genetic Counseling.

Djurdjinovic L, Peters JA.

J Genet Couns. 2017 Apr;26(2):1-4. doi: 10.1007/s10897-017-0080-0. Epub 2017 Mar 7. No abstract available.

PMID:
28271394
31.

Agents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis.

Nathavitharana RR, Bond P, Dramowski A, Kotze K, Lederer P, Oxley I, Peters JA, Rossouw C, van der Westhuizen HM, Willems B, Ting TX, von Delft A, von Delft D, Duarte R, Nardell E, Zumla A.

Presse Med. 2017 Mar;46(2 Pt 2):e53-e62. doi: 10.1016/j.lpm.2017.01.014. Epub 2017 Feb 28. Review.

32.

Correction: Statistically-Estimated Tree Composition for the Northeastern United States at Euro-American Settlement.

Paciorek CJ, Goring SJ, Thurman AL, Cogbill CV, Williams JW, Mladenoff DJ, Peters JA, Zhu J, McLachlan JS.

PLoS One. 2017 Jan 20;12(1):e0170835. doi: 10.1371/journal.pone.0170835. eCollection 2017.

33.

Erratum to: Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial.

Gupta-Wright A, Fielding KL, van Oosterhout JJ, Wilson DK, Corbett EL, Flach C, Reddy KP, Walensky RP, Peters JA, Alufandika-Moyo M, Lawn SD.

BMC Infect Dis. 2016 Oct 25;16(1):604. No abstract available.

34.

Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial.

Gupta-Wright A, Fielding KL, van Oosterhout JJ, Wilson DK, Corbett EL, Flach C, Reddy KP, Walensky RP, Peters JA, Alufandika-Moyo M, Lawn SD.

BMC Infect Dis. 2016 Sep 22;16(1):501. Erratum in: BMC Infect Dis. 2016 Oct 25;16(1):604.

35.

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.

Mai PL, Best AF, Peters JA, DeCastro RM, Khincha PP, Loud JT, Bremer RC, Rosenberg PS, Savage SA.

Cancer. 2016 Dec 1;122(23):3673-3681. doi: 10.1002/cncr.30248. Epub 2016 Aug 6.

36.

THE ELEPHANT IN THE OR: IMPROVING PERFORMANCE FOR LONG SURGICAL CASES.

Bosco UJ, Peters JA, Torrance A.

Physician Leadersh J. 2016 May-Jun;3(3):8-12. No abstract available.

PMID:
27295738
37.

Research participant interest in primary, secondary, and incidental genomic findings.

Loud JT, Bremer RC, Mai PL, Peters JA, Giri N, Stewart DR, Greene MH, Alter BP, Savage SA.

Genet Med. 2016 Dec;18(12):1218-1225. doi: 10.1038/gim.2016.36. Epub 2016 Apr 21.

38.

The reliability of parameters obtained by fitting of (1)H NMRD profiles and (17)O NMR data of potential Gd(3+)-based MRI contrast agents.

Peters JA.

Contrast Media Mol Imaging. 2016 Mar-Apr;11(2):160-8. doi: 10.1002/cmmi.1677. Epub 2015 Dec 21.

PMID:
27041694
40.

Statistically-Estimated Tree Composition for the Northeastern United States at Euro-American Settlement.

Paciorek CJ, Goring SJ, Thurman AL, Cogbill CV, Williams JW, Mladenoff DJ, Peters JA, Zhu J, McLachlan JS.

PLoS One. 2016 Feb 26;11(2):e0150087. doi: 10.1371/journal.pone.0150087. eCollection 2016. Erratum in: PLoS One. 2017 Jan 20;12 (1):e0170835.

41.

FabAV antivenin use after copperhead snakebite: clinically indicated or knee-jerk reaction?

Gale SC, Peters JA, Allen L, Creath R, Dombrovskiy VY.

J Venom Anim Toxins Incl Trop Dis. 2016 Jan 13;22:2. doi: 10.1186/s40409-016-0056-9. eCollection 2016.

42.

The Concise Guide to PHARMACOLOGY 2015/16: Transporters.

Alexander SP, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2015 Dec;172(24):6110-202. doi: 10.1111/bph.13355.

43.

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes.

Alexander SP, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2015 Dec;172(24):6024-109. doi: 10.1111/bph.13354.

44.

The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors.

Alexander SP, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2015 Dec;172(24):5979-6023. doi: 10.1111/bph.13353.

45.

The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors.

Alexander SP, Cidlowski JA, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2015 Dec;172(24):5956-78. doi: 10.1111/bph.13352.

46.

The Concise Guide to PHARMACOLOGY 2015/16: Other ion channels.

Alexander SP, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2015 Dec;172(24):5942-55. doi: 10.1111/bph.13351.

47.

The Concise Guide to PHARMACOLOGY 2015/16: Voltage-gated ion channels.

Alexander SP, Catterall WA, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2015 Dec;172(24):5904-41. doi: 10.1111/bph.13349.

48.

The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels.

Alexander SP, Peters JA, Kelly E, Marrion N, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2015 Dec;172(24):5870-903. doi: 10.1111/bph.13350.

49.

The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors.

Alexander SP, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2015 Dec;172(24):5744-869. doi: 10.1111/bph.13348.

50.

The Concise Guide to PHARMACOLOGY 2015/16: Overview.

Alexander SP, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Buneman OP, Catterall WA, Cidlowski JA, Davenport AP, Fabbro D, Fan G, McGrath JC, Spedding M, Davies JA; CGTP Collaborators.

Br J Pharmacol. 2015 Dec;172(24):5729-43. doi: 10.1111/bph.13347.

Supplemental Content

Loading ...
Support Center